Brinter

Collaboration with SRM AP University in India

https://www.brinter.com/srm-ap

Brinter collaborates with SRM University AP in India, ushering in a new era of innovation and research in the faculty of Engineering and Sciences. Brinter’s state-of-the-art multi-material printer is capable of producing complex biological structures, such as tissues and organs, and other engineered materials with remarkable accuracy and precision. The partnership was in collaboration with 3D printer expert Sumant Bhutoria of Alfatek.

The collaboration allows researchers to create new models that closely mimic the structure and function of human organs or for example bioelectronics. This development could prove to be a game-changer in the field.

The Brinter ONE 3D Bioprinter is able to use a combination of materials, including cells to create 3D models of for example bioelectronic components or human tissues and organs. This allows researchers to test products, develop new materials, and study new structures with unprecedented precision. Brinter ONE’s ability to print complex structures with high accuracy and speed is also expected to reduce the cost of research and accelerate the development of new products.

It is expected that this will lead to new collaborations and partnerships between SRM and other Indian and international research institutions, and pave the way for more game changing discoveries in the future.

Brinter collaboration with SRM AP University in India Brinter collaboration with SRM AP University in India Brinter collaborates with SRM University AP in India, ushering in a new era of innovation and research in the faculty of Engineering and Sciences. Brinter's state-of-the-art multi-material printer is capable

Brinter Makes Waves at MedInvest Conference 2023

Key Takeaways from Brinter’s Presence in the MedTech Industry’s Premier Investor Event

https://www.brinter.com/medinvest-insights

The MedInvest Conference 2023 held in Palo Alto on March 28-29 brought together investors, industry professionals, and biotech enthusiasts to discuss the latest advancements in the medical technology sector. One of the most talked-about companies at the event was Brinter, a leader in 3D bioprinting technology, with its CEO Tomi Alapaattikoski in attendance. The conference proved to be an excellent platform for Brinter to showcase its pioneering work and to connect with potential investors.

The MedInvest Conference proved to be an excellent opportunity for Brinter to connect with potential investors. With its groundbreaking technology and promising applications, the company caught the eye of numerous venture capitalists and investment firms. These connections could lead to future funding rounds, enabling Brinter to continue its research and development efforts, as well as scale its operations.

The MedInvest Conference 2023 proved to be an invaluable platform for Brinter and its CEO Tom Alapaattikoski. The event not only showcased the company’s groundbreaking 3D bioprinting technology, but also fostered connections with potential investors and industry professionals. With the continued commitment to collaboration and innovation, Brinter is poised to be a driving force in the field of regenerative medicine and personalized healthcare.

Brinter Makes Waves at MedInvest Conference 2023 Brinter Makes Waves at MedInvest Conference 2023